Giloralimab (Anti-TNFRSF5 / CD40)

Giloralimab (Anti-TNFRSF5 / CD40) is an agonistic monoclonal antibody directed against the B-cell surface antigen CD40 with potential antineoplastic activity. MW: 145.26 KD.
Supplier Selleck Chemicals
Product # A2884
Sku # A2884-1mg*5
Pricing 1mg*5, $1690.00
Feedback